Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Weber

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Chemmedchem|February 21, 2022
Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide-Based Hybrid Compounds against SARS-CoV-2 and CancerLars Herrmann, Ivan A Yaremenko, Aysun Çapcı, et al.
Plos One|June 4, 2016
Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic CellsBesma Aouar, Denisa Kovarova, Sebastien Letard, et al.
Journal of Medicinal Chemistry|April 22, 2015
Highly Selective Phosphatidylinositol 4-Kinase IIIβ Inhibitors and Structural Insight into Their Mode of ActionIvana Mejdrová, Dominika Chalupská, Martin Kögler, et al.
Scientific Reports|November 10, 2023
Mannich-type modifications of (-)-cannabidiol and (-)-cannabigerol leading to new, bioactive derivativesEszter Boglárka Lőrincz, Gergely Tóth, Júlia Spolárics, et al.
RSC Medicinal Chemistry|September 2, 2024
Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5'-carboxamidesHugo Kocek, Dominika Chalupská, Milan Dejmek, et al.
ACS Omega|August 7, 2023
Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase InhibitorsMilan Štefek, Dominika Chalupská, Karel Chalupský, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
Impact on replicative fitness of the G48E substitution in the protease of HIV-1: an in vitro and in silico evaluationJean-Marie Zimmer, François Roman, Christine Lambert, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 15, 2023
Detection of viable SARS-CoV-2 on the hands of hospitalized children with COVID-19Meryl Haas, Paola Fürhacker, Jan Hodek, et al.
ACS Chemical Biology|May 15, 2024
HIV-1 Infection Reduces NAD Capping of Host Cell snRNA and snoRNABarbora Benoni, Jiří František Potužník, Anton Škríba, et al.
Journal of Molecular Biology|December 4, 2002
Unusual binding mode of an HIV-1 protease inhibitor explains its potency against multi-drug-resistant virus strainsJan Weber, Jeroen R Mesters, Martin Lepsík, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Chemmedchem|February 21, 2022
Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide-Based Hybrid Compounds against SARS-CoV-2 and CancerLars Herrmann, Ivan A Yaremenko, Aysun Çapcı, et al.
Plos One|June 4, 2016
Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic CellsBesma Aouar, Denisa Kovarova, Sebastien Letard, et al.
Journal of Medicinal Chemistry|April 22, 2015
Highly Selective Phosphatidylinositol 4-Kinase IIIβ Inhibitors and Structural Insight into Their Mode of ActionIvana Mejdrová, Dominika Chalupská, Martin Kögler, et al.
Scientific Reports|November 10, 2023
Mannich-type modifications of (-)-cannabidiol and (-)-cannabigerol leading to new, bioactive derivativesEszter Boglárka Lőrincz, Gergely Tóth, Júlia Spolárics, et al.
RSC Medicinal Chemistry|September 2, 2024
Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5'-carboxamidesHugo Kocek, Dominika Chalupská, Milan Dejmek, et al.
ACS Omega|August 7, 2023
Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase InhibitorsMilan Štefek, Dominika Chalupská, Karel Chalupský, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
Impact on replicative fitness of the G48E substitution in the protease of HIV-1: an in vitro and in silico evaluationJean-Marie Zimmer, François Roman, Christine Lambert, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 15, 2023
Detection of viable SARS-CoV-2 on the hands of hospitalized children with COVID-19Meryl Haas, Paola Fürhacker, Jan Hodek, et al.
ACS Chemical Biology|May 15, 2024
HIV-1 Infection Reduces NAD Capping of Host Cell snRNA and snoRNABarbora Benoni, Jiří František Potužník, Anton Škríba, et al.
Journal of Molecular Biology|December 4, 2002
Unusual binding mode of an HIV-1 protease inhibitor explains its potency against multi-drug-resistant virus strainsJan Weber, Jeroen R Mesters, Martin Lepsík, et al.
Pageof 14